PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China · Delayed Price · Currency is CNY

37.02

-0.39 (-1.04%)

May 20, 2026, 12:35 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug R&D and Production Related Business	1.97B	1.69B	1.73B	1.59B	1.20B
Drug R&D and Production Related Business Growth	16.93%	-2.12%	8.18%	32.71%	17.55%
Total	1.97B	1.69B	1.73B	1.59B	1.20B
Total Growth	16.93%	-2.12%	8.18%	32.71%	17.55%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	539.88M	448.70M	543.70M	488.58M	-
China Growth	20.32%	-17.47%	11.28%	-	-
Foreign	1.43B	1.24B	1.18B	1.11B	-
Foreign Growth	15.70%	4.94%	6.81%	-	-
Total	1.97B	1.69B	1.73B	1.59B	-
Total Growth	16.93%	-2.12%	8.18%	-	-

Source: S&P Global Market Intelligence.